↓ Skip to main content

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

Overview of attention for article published in Molecular Cancer, December 2012
Altmetric Badge

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
44 Mendeley